Skip to content
MarketScale
‹ Back to Industries

Sciences

THE IMPORTANT ROLE OF PROBIOTICS IN SPORTS NUTRITION

Athletes and fitness enthusiasts work hard to improve their health and conditioning. However, they sometimes have issues with their digestion and immunity even as they strive to improve their physical performance. The probiotic strain Bacillus subtilis DE111 can help give fitness enthusiasts and serious athletes a performance boost. The Sports Nutrition Market is Growing Rapidly…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Promoted Content
Share
THE IMPORTANT ROLE OF PROBIOTICS IN SPORTS NUTRITION

Key takeaways

01

Athletes and fitness enthusiasts work hard to improve their health and conditioning.

02

However, they sometimes have issues with their digestion and immunity even as they strive to improve their physical performance.

03

The probiotic strain Bacillus subtilis DE111 can help give fitness enthusiasts and serious athletes a performance boost.

Athletes and fitness enthusiasts work hard to improve their health and conditioning. However, they sometimes have issues with their digestion and immunity even as they strive to improve their physical performance. The probiotic strain Bacillus subtilis DE111 can help give fitness enthusiasts and serious athletes a performance boost.

The Sports Nutrition Market is Growing Rapidly

Sports nutrition is the leading projected growth sector in global healthcare, far outpacing other areas such as OTC, vitamin and dietary supplements, and weight management. A recent report by Zion Market Research estimates the global sports nutrition market will grow about 8% annually over the next few years, reaching over $45 billion by 2022. The category includes products such as sports drinks, meal replacement drinks, protein powder, nutrition bars, and dietary supplements that are consumed by professional and amateur athletes to improve their overall health, performance, and muscle growth. Typical goals of a sports nutrition program include muscle and strength building, weight loss, cardiovascular improvement, increased energy, and better sleep.

Athletes May Suffer from Digestive Issues

Despite their typical healthy appearance, athletes may suffer from a number of digestive issues. In facts, studies show that 30% to 50% of athletes and up to 93% of long-distance triathletes suffer from gastrointestinal problems. These issues can occur before, during, or after an exercise session or a competition. Gastrointestinal issues can impair performance or recovery by causing electrolytes imbalance, sleep disturbance, and dehydration. Additionally, a recent study of a group of ultra-marathon runners found 89% experienced nausea, 44% had abdominal cramps, and 44% suffered from diarrhea.

Probiotic Supplements Can Help Ease Gastrointestinal Issues in Athletes

Probiotic supplements boost athletic performance many important ways. First, they help optimize digestion by increasing the absorption of nutrients and digestion of protein, providing the building blocks for muscle building and recovery. Probiotics accomplish this by maintaining levels of healthy bacteria in the gut that aid in the digestion of macronutrients, allowing for optimized nutrient uptake from food. Next, they help strengthen immunity by increasing the absorption of antioxidants making athletes less susceptible to sickness and infection. Finally, they minimize common GI issues, decreasing the occurrence of athlete’s diarrhea, gas, bloating, and heartburn.

Studies Show DE111 Probiotic Can Help in Sports Nutrition

The probiotic strain Bacillus subtilis DE111 from Deerland Probiotics & Enzymes is a spore-forming strain that helps provide a competitive edge to athletes. For example, in a study on the effects of supplementation during offseason resistance training in female Division I athletes, DE111 produced significant improvements in body composition when consumed in conjunction with a high-protein recovery drink. It also helped improve lower body strength as determined by the deadlift 1-repetition maximum. In a separate study on the effect of DE111 on the daily bowel movement profile for people with occasional gastrointestinal irregularity, DE111 helped improve gastrointestinal discomfort including constipation and diarrhea. Participants also reported an increased frequency of normal type stools compared to those in the placebo group.

The DE111 strain is genome sequenced for safety, remains viable under wide temperature range, and survives passage through the acidic environment of GI tract to help crowd out bacterial pathogens and maintain healthy gut barrier function. To find out more about how DE111 can help in sports nutrition, download this white paper.

About the author

S
Sciences

New to MarketScale?

MarketScale is the platform Sciences companies use to turn their own experts into content like this. Want the short overview?

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

At Paris Packaging Week 2026, Tekniplex showcased its latest sustainable materials innovations, emphasizing the intersection of materials science and brand storytelling. The company's booth featured a living wall and digital displays to engage a sustainability-conscious audience, highlighting advanced materials for sustainability and product performance in cosmetics packaging.

  • 01Tekniplex emphasized sustainable materials innovation at Paris Packaging Week 2026.
  • 02The company's booth featured eco-friendly design elements and immersive digital displays.
  • 03Tekniplex highlighted advancements in recyclable sealing systems and materials for cosmetics.

Apr 9, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences